ArticleScientific reports2025
Effect of oxytocin on cardiovascular modulation in normal and post-traumatic stress disorder model rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Oxytocin (OXT) is associated with cardioprotective effects and shows to alleviate symptoms of post-traumatic stress disorder (PTSD). This study investigates blood pressure and electrocardiographic (ECG) parameters in anesthetized normal rats utilizing intravenous (iv) and intracerebroventricular (icv) administration of oxytocinergic agents. We also assessed the effects of cervical vagotomy on the cardiovascular responses to iv OXT. Furthermore, we compared the cardiovascular responses to iv OXT in PTSD model rats with those in normal controls. The mean arterial pressure (MAP), mean heart rate (HR) and the standard deviation of normal-to-normal intervals (SDNN, an indicator of HR variability) were measured and analyzed. Results showed that iv, rather than icv, administration of OXT led to a concentration-dependent increase in MAP, a decrease in HR, and an increase in the SDNN. Cervical vagotomy did not significantly alter the MAP responses but reduced cardiac activities (both HR and SDNN) during OXT stimulation. PTSD model rats exhibited higher baseline MAP and HR, but showed a diminished cardiovascular response to OXT compared to normal rats. These findings suggest that OXT induces distinct cardiovascular effects in normal versus PTSD model rats, underscoring the need to consider the cardiovascular implications of OXT in clinical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.